Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.
<h4>Background</h4>Liver biopsy is the reference standard for assessing liver fibrosis and no reliable non-invasive diagnostic approach is available to discriminate between the intermediate stages of fibrosis. Therefore suitable serological biomarkers of liver fibrosis are urgently neede...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0039603&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850224747425562624 |
|---|---|
| author | Bevin Gangadharan Manisha Bapat Jan Rossa Robin Antrobus David Chittenden Bettina Kampa Eleanor Barnes Paul Klenerman Raymond A Dwek Nicole Zitzmann |
| author_facet | Bevin Gangadharan Manisha Bapat Jan Rossa Robin Antrobus David Chittenden Bettina Kampa Eleanor Barnes Paul Klenerman Raymond A Dwek Nicole Zitzmann |
| author_sort | Bevin Gangadharan |
| collection | DOAJ |
| description | <h4>Background</h4>Liver biopsy is the reference standard for assessing liver fibrosis and no reliable non-invasive diagnostic approach is available to discriminate between the intermediate stages of fibrosis. Therefore suitable serological biomarkers of liver fibrosis are urgently needed. We used proteomics to identify novel fibrosis biomarkers in hepatitis C patients with different degrees of liver fibrosis.<h4>Methodology/principal findings</h4>Proteins in plasma samples from healthy control individuals and patients with hepatitis C virus (HCV) induced cirrhosis were analysed using a proteomics technique: two dimensional gel electrophoresis (2-DE). This technique separated the proteins in plasma samples of control and cirrhotic patients and by visualizing the separated proteins we were able to identify proteins which were increasing or decreasing in hepatic cirrhosis. Identified markers were validated across all Ishak fibrosis stages and compared to the markers used in FibroTest, Enhanced Liver Fibrosis (ELF) test, Hepascore and FIBROSpect by Western blotting. Forty four candidate biomarkers for hepatic fibrosis were identified of which 20 were novel biomarkers of liver fibrosis. Western blot validation of all candidate markers using plasma samples from patients across all Ishak fibrosis scores showed that the markers which changed with increasing fibrosis most consistently included lipid transfer inhibitor protein, complement C3d, corticosteroid-binding globulin, apolipoprotein J and apolipoprotein L1. These five novel fibrosis markers which are secreted in blood showed a promising consistent change with increasing fibrosis stage when compared to the markers used for the FibroTest, ELF test, Hepascore and FIBROSpect. These markers will be further validated using a large clinical cohort.<h4>Conclusions/significance</h4>This study identifies 20 novel fibrosis biomarker candidates. The proteins identified may help to assess hepatic fibrosis and eliminate the need for invasive liver biopsies. |
| format | Article |
| id | doaj-art-487aba4996184ce7a069b33f37eb7633 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-487aba4996184ce7a069b33f37eb76332025-08-20T02:05:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0176e3960310.1371/journal.pone.0039603Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.Bevin GangadharanManisha BapatJan RossaRobin AntrobusDavid ChittendenBettina KampaEleanor BarnesPaul KlenermanRaymond A DwekNicole Zitzmann<h4>Background</h4>Liver biopsy is the reference standard for assessing liver fibrosis and no reliable non-invasive diagnostic approach is available to discriminate between the intermediate stages of fibrosis. Therefore suitable serological biomarkers of liver fibrosis are urgently needed. We used proteomics to identify novel fibrosis biomarkers in hepatitis C patients with different degrees of liver fibrosis.<h4>Methodology/principal findings</h4>Proteins in plasma samples from healthy control individuals and patients with hepatitis C virus (HCV) induced cirrhosis were analysed using a proteomics technique: two dimensional gel electrophoresis (2-DE). This technique separated the proteins in plasma samples of control and cirrhotic patients and by visualizing the separated proteins we were able to identify proteins which were increasing or decreasing in hepatic cirrhosis. Identified markers were validated across all Ishak fibrosis stages and compared to the markers used in FibroTest, Enhanced Liver Fibrosis (ELF) test, Hepascore and FIBROSpect by Western blotting. Forty four candidate biomarkers for hepatic fibrosis were identified of which 20 were novel biomarkers of liver fibrosis. Western blot validation of all candidate markers using plasma samples from patients across all Ishak fibrosis scores showed that the markers which changed with increasing fibrosis most consistently included lipid transfer inhibitor protein, complement C3d, corticosteroid-binding globulin, apolipoprotein J and apolipoprotein L1. These five novel fibrosis markers which are secreted in blood showed a promising consistent change with increasing fibrosis stage when compared to the markers used for the FibroTest, ELF test, Hepascore and FIBROSpect. These markers will be further validated using a large clinical cohort.<h4>Conclusions/significance</h4>This study identifies 20 novel fibrosis biomarker candidates. The proteins identified may help to assess hepatic fibrosis and eliminate the need for invasive liver biopsies.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0039603&type=printable |
| spellingShingle | Bevin Gangadharan Manisha Bapat Jan Rossa Robin Antrobus David Chittenden Bettina Kampa Eleanor Barnes Paul Klenerman Raymond A Dwek Nicole Zitzmann Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study. PLoS ONE |
| title | Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study. |
| title_full | Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study. |
| title_fullStr | Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study. |
| title_full_unstemmed | Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study. |
| title_short | Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study. |
| title_sort | discovery of novel biomarker candidates for liver fibrosis in hepatitis c patients a preliminary study |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0039603&type=printable |
| work_keys_str_mv | AT bevingangadharan discoveryofnovelbiomarkercandidatesforliverfibrosisinhepatitiscpatientsapreliminarystudy AT manishabapat discoveryofnovelbiomarkercandidatesforliverfibrosisinhepatitiscpatientsapreliminarystudy AT janrossa discoveryofnovelbiomarkercandidatesforliverfibrosisinhepatitiscpatientsapreliminarystudy AT robinantrobus discoveryofnovelbiomarkercandidatesforliverfibrosisinhepatitiscpatientsapreliminarystudy AT davidchittenden discoveryofnovelbiomarkercandidatesforliverfibrosisinhepatitiscpatientsapreliminarystudy AT bettinakampa discoveryofnovelbiomarkercandidatesforliverfibrosisinhepatitiscpatientsapreliminarystudy AT eleanorbarnes discoveryofnovelbiomarkercandidatesforliverfibrosisinhepatitiscpatientsapreliminarystudy AT paulklenerman discoveryofnovelbiomarkercandidatesforliverfibrosisinhepatitiscpatientsapreliminarystudy AT raymondadwek discoveryofnovelbiomarkercandidatesforliverfibrosisinhepatitiscpatientsapreliminarystudy AT nicolezitzmann discoveryofnovelbiomarkercandidatesforliverfibrosisinhepatitiscpatientsapreliminarystudy |